Products for Research Use Only
RegisterLogin

Tifcemalimab

CAT: 0804-HY-P99961-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99961-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Tifcemalimab (JS004) is a humanized anti-BTLA (B and T lymphocyte attenuation factor) monoclonal antibody. Tifcemalimab blocks the interaction of HVEM-BTLA by binding to BTLA, and thus blocks the inhibitory signaling pathway mediated by BTLA. Tifcemalimab can be used in research of cancer, such as lymphoma and non-small cell lung cancer (NSCLC) [1][2].
CAS Number
2236068-83-8
Product Name Alternative
JS004; Icatolimab
UNSPSC
12352203
Target
CD28
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/tifcemalimab.html
Purity
96.02
Solubility
10 mM in DMSO
Smiles
[Tifcemalimab]
Molecular Weight
(146 kDa)
References & Citations
[1]Jun Ma, et al. Phase I Study of the Anti-Btla Antibody Tifcemalimab As a Single Agent or in Combination with Toripalimab in Relapsed/Refractory Lymphomas. Blood (2022) 140 (Supplement 1) : 3716–3717.|[2]D. Lv, et al. Tifcemalimab combined with toripalimab and docetaxel as 2nd line treatment for immunotherapy-treated squamous cell non-small cell lung cancer (Sq-NSCLC) patients: A phase Ib/II study - Annals of Oncology. Volume 35, Supplement 4S1645December 2024.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
abx831787-01Tifcemalimab
GTR18337946-01Tifcemalimab Antibody
MBS1563878-01Research Grade Tifcemalimab
E55B0439Tifcemalimab (Reference antibody)
ICH5920-25mgTifcemalimab Biosimilar - Research Grade
047916BTLA/CD272 (Tifcemalimab) discontinued
A138585Tifcemalimab Biosimilar (Monoclonal, IgG4)
GTR18697765-01Tifcemalimab Chimeric Monoclonal Antibody
GTR18780799-01(Tifcemalimab) Biosimilar Reference Antibody
F1387-5Anti-BTLA/CD272 Antibody (Tifcemalimab)

Popular Products